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A genetic screen for suppressors of bile sensitivity in DNA adenine methylase (dam) mutants of Salmonella
enterica serovar Typhimurium yielded insertions in an uncharacterized locus homologous to the Escherichia coli
asmA gene. Disruption of asmA suppressed bile sensitivity also in phoP and wec mutants of S. enterica and
increased the MIC of sodium deoxycholate for the parental strain ATCC 14028. Increased levels of marA
mRNA were found in asmA, asmA dam, asmA phoP, and asmA wec strains of S. enterica, suggesting that lack of
AsmA activates expression of the marRAB operon. Hence, asmA mutations may enhance bile resistance by
inducing gene expression changes in the marRAB-controlled Mar regulon. In silico analysis of AsmA structure
predicted the existence of one transmembrane domain. Biochemical analysis of subcellular fractions revealed
that the asmA gene of S. enterica encodes a protein of 70 kDa located in the outer membrane. Because AsmA
is unrelated to known transport and/or efflux systems, we propose that activation of marRAB in asmA mutants
may be a consequence of envelope reorganization. Competitive infection of BALB/c mice with asmA and asmA
isogenic strains indicated that lack of AsmA attenuates Salmonella virulence by the oral route but not by the
intraperitoneal route. Furthermore, asmA mutants showed a reduced ability to invade epithelial cells in vitro.
Bile is a fluid containing cholesterol, bile salts, phospholip-
ids, proteins, bilirubin, and a variety of electrolytes (23). A
fraction of the bile synthesized in the liver flows directly into
the small intestine, while another fraction is stored in the
gallbladder and released into the duodenum during food pas-
sage. About two-thirds (dry weight) of bile is made of bile salts,
a family of molecules with steroid structure which derive from
cholesterol (23). Aside from their role in digestion, bile salts
have two distinct antibacterial activities, as detergents that
disrupt the bacterial envelope and as DNA-damaging agents
(5, 18, 39).
The mechanisms employed by Escherichia coli and Salmo-
nella enterica to survive in the presence of bile are diverse and
only partially understood (18) and involve a variety of cell
functions: envelope structures that provide physical barriers to
bile salts (31, 45, 55), efflux pumps that transport bile salts
outside the cell (34, 38, 46, 52), and DNA repair functions that
maintain genome integrity (39, 40). Resistance to bile is espe-
cially relevant in Salmonella physiology, since systemic infec-
tion leads to colonization of the hepatobiliary tract (35), where
the concentration of bile is high and steady (23). Furthermore,
the gallbladder is a major niche for Salmonella in chronic
carriers of Salmonella enterica serovar Typhi (14). The ability
of Salmonella to survive in the mammalian gallbladder reflects
its ability to adapt to virtually any concentration of bile (18)
and to form biofilms on the surface of gallstones (9, 42, 43).
A strategy that has proven useful to identify cellular func-
tions required for bile resistance in S. enterica is the isolation of
bile-sensitive mutants and the subsequent identification of the
mutations involved. In certain cases, however, mutation iden-
tification does not permit straightforward inference of the
mechanisms whose disruption causes bile sensitivity. An exam-
ple of this kind is found in S. enterica mutants lacking DNA
adenine methylase (Dam), which suffer pleiotropic virulence
effects including extreme bile sensitivity (15, 21, 22, 44). How-
ever, a functional relationship between DNA methylation and
bile resistance is by no means obvious. In such circumstances,
a strategy of classical genetics that can identify genetic partners
is suppressor analysis: mutations that suppress a mutant phe-
notype often affect genes involved in the process under study
(20). In the case of Salmonella dam mutants, their extreme bile
sensitivity makes suppressor analysis easy: plating of a dam-
null mutant on a medium containing ox bile produces bile-
resistant revertants that carry extragenic suppressor mutations
(39). Using this strategy, a previous study showed that bile
sensitivity in Salmonella dam mutants was suppressed by inac-
tivation of the Dam-dependent mismatch repair system,
MutHLS (39). Below we describe the characterization of a
second, unsuspected class of suppressors of bile sensitivity in
Salmonella dam mutants, involving loss of function in an S.
enterica locus homologous to the asmA gene of Escherichia
coli.
In E. coli, AsmA appears to be involved in preventing mis-
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folding of outer membrane proteins (OMPs), but its precise
role has not been established. Mutations in asmA were initially
described as suppressors that permitted assembly of mutant
OmpF proteins (29), a role later extended to mutant OmpC
proteins (56). The idea of involvement of AsmA in the assem-
bly of wild-type OMPs was, however, discarded (30). An inter-
pretation was that the presence of AsmA might create an
environment refractory to the assembly of mutant (misfolded)
OMPs (11). In the absence of AsmA, a more permissive envi-
ronment would thus permit mutant OMP assembly (11). For
Salmonella enterica, the only AsmA reference in the literature
is a recent study that found asmA among the genes required
for survival of Salmonella enterica serovar Typhimurium in the
swine gastric environment (4). We show that the asmA gene of
S. enterica encodes an OMP. The absence of AsmA in the
outer membrane enhances bile resistance in diverse genetic
backgrounds, presumably by increasing marRAB expression.
We propose that marRAB transcriptional activation in the ab-
sence of AsmA may be an indirect consequence of an envelope
rearrangement associated with loss of this OMP. Another con-
sequence of AsmA absence is attenuation of virulence by the
oral route, which can be tentatively correlated with the re-
duced ability of S. enterica asmA mutants to invade cultured
epithelial cells.
MATERIALS AND METHODS
Bacterial strains, bacteriophages, and plasmids. The strains of Salmonella
enterica used in this study (Table 1) belong to Salmonella serovar Typhimurium
and derive from the mouse-virulent strain ATCC 14028. Exceptions are the LT2
derivatives TT1704 and TT10288, obtained from J. R. Roth, University of Cal-
ifornia, Davis, CA. E. coli DH5 was the standard host for recombinant plasmids
(57). Plasmid pGE108 (Kmr) is a ColE1 derivative carrying a cea::lacZ fusion
(47). pIZ1581 is a pBAD18 derivative expressing the S. enterica asmA gene from
the arabinose-dependent pBAD promoter (see below). pIZ53 is a pUC19 deriv-
ative carrying the internal HindIII fragment of Tn5; this fragment includes the
kanamycin resistance gene (26). Transductional crosses using phage P22 HT
105/1 int201 (48; G. Roberts, unpublished data) were used for strain construction
operations involving chromosomal markers and for transfer of plasmids among
Salmonella strains. The transduction protocol was described elsewhere (16). To
obtain phage-free isolates, transductants were purified by being streaked on
green plates (7). Phage sensitivity was tested by cross-streaking with the clear-
plaque mutant P22 H5.
Construction of pIZ1581. The asmA gene of S. enterica ATCC 14028 was PCR
amplified using primers 5 CAT GGA GCT C CTG AGC CAT TCG GCG CAA
TAC 3 and 5 CAT GT CTA GAG ATG TAA CGT CTG TTC GCC TG 3.
Underlined are the SacI and XbaI restriction sites used for digestion of the
amplified fragment, which was then cloned onto pBAD18 (19).
Construction of asmA, dcd, udk, tolC, and marA mutants. Targeted disruption
of the asmA, dcd, udk, and marA genes was achieved by the procedure of
Datsenko and Wanner (10). Antibiotic resistance cassettes introduced during
construction were excised by recombination with plasmid pCP20 (10). The oli-
gonucleotides used for disruption were as follows: for asmA, 5 TGC CGG TCC
ATT GAG GGT AGC ATG AGA CGA TTT CTG GTG TAG GCT GGA GCT
GCT TC 3 and 5 CTC GCC ATC CGG CTC TGC CCT TTG GCC AAA AAC
TAC CAT ATG AAT ATC CTC CTT AG 3; for dcd, 5 TAA GGG CTT GAT
GCG CGA AAG GAG AAA GTG CCA TGC GTG TAG GCT GGA GCT
GCT TC 3 and 5GGC AGT ATT GCG CCG AAT GGC TCA GTC TTT ATC
AAT CAT ATG AAT ATC CTC CTT AG 3; for udk, 5 TTA CAT CCA GGT
TAA TCA GGT CGC TAA ATT TAT GAC GTG TAG GCT GGA GCT GCT
TC 3 and 5GGT TAT CAC TGA ACG GTA CAC AAT TCG CCA GAT TTA
CAT ATG AAT ATC CTC CTT AG 3; for tolC, 5 AGC CAG GCA GAG
AAC CTG ATG CAA GTT TAT CAG CAA GCA CGT GTA GGC TGG AGC
TGC TTC 3 and 5 GGT CTG ATA AGC GCA GCG CCA GCG AAT AAC
TTA TCA ATG CCA TAT GAA TAT CCT CCT TAG 3; and for marA, 5 CTT
AAC GGC GGAC GAA GTG GCA ACG CTT GAG TAT TTG CTC TGT
AGG CTG GAG CTG CTT CG 3 and 5 GTG CTC TTC GCG TGG CGC
ATA AAC AAA CTA GTA GTT GCC CAT ATG AAT ATC CTC CTT AG 3.
The following external primers were employed for PCR amplification of the
resulting alleles: for asmA::Kmr and asmA, 5 CAT GGA GCT CCT GAG
CCA TTC GGC GCA ATA C 3 and 5 ATG AGC AAT ACG CGC CTT GAA
G 3; for dcd::Kmr, 5 GTT CAG TGA TAA CCT GGT TAG 3 and 5 AGC
GTC GTC AGA AAT CGT CTC 3; for udk::Kmr, 5 CCC TAT AAT TGC
CGC GTT TG 3 and 5 GCC CTT AAA TCA AGC ACA TC 3; for tolC::Cmr,
5 TGG CGG ATT CTG CTA GAA TC 3 and 5 TGG CGG ATT CTG CTA
GAA TC 3; and for marA::Kmr, 5 TAT CCC CGC TGG ATA TCA C 3 and
5 TCA GCG GAT GAG GCA TTA TG 3. PCR amplification products were
sequenced at the facilities of Sistemas Geno´micos SL, Paterna, Valencia, Spain.
Medium and culture conditions. Luria-Bertani broth (LB) was used in all
experiments. Unless otherwise indicated, the carbon source was 0.2% glucose.
Arabinose was used at the final concentration of 0.2%. Solid LB contained agar
at a 1.5% final concentration. Green plates were prepared according to the
method of Chan et al. (7), except that methyl blue (Sigma) was used instead of
aniline blue. Antibiotics were used at the final concentrations described previ-
ously (53). Deoxycholic acid (sodium salt) was from Sigma Chemical Co., St.
Louis, MO.
MICs of DOC and tetracycline. Exponential cultures in LB were prepared as
previously described. Samples containing around 3  102 CFU were transferred
to polypropylene microtiter plates (Soria Genlab, Valdemoro, Spain) containing
known amounts of sodium deoxycholate (DOC) or tetracycline. After 12 h of
incubation at 37°C, growth was visually monitored. Assays were carried out in
triplicate.
Mutagenesis with MudJ. A P22 HT lysate grown on strain TT10288 was used
to transduce TT1704, selecting kanamycin resistance (24). The recipient strain
carried the nontransducible deletion his-9533. Transductants were selected on
LB supplemented with kanamycin. Kmr transductants were made phage free by
replica printing (2 times) to LB plates containing 10 mM EGTA. Pools of500
colonies were prepared and lysed with P22. These pools were then used to
transduce SV4392, and Kmr transductants were selected on plates containing 1%
DOC (39).
Characterization of MudJ insertion sites in the Salmonella chromosome. A
genomic DNA preparation (500 ng) from the strain carrying the MudJ insert was
digested with either SmaI plus SspI or SmaI plus EcoRV. The sizes of the
resulting DNA fragments were determined by Southern hybridization, using the
TABLE 1. Strains of Salmonella enterica serovar Typhimurium
Strain Genotype Referenceor source
SV4392 dam201::Tn10dTc 39
SV4429 wecD::MudJ 45
SV4536 dam230 39
SV4699 phoP7953::Tn10 Lab stock
SV4704 asmA1::MudJ dam201::Tn10dTc This study
SV4708 asmA1::MudJ This study
SV4742 dam230/pIZ1581 This study
SV4759 wecA::Tn10dTc This study
SV4813 wecA::Tn10dTc asmA::MudJ This study
SV4873 trg::MudJ 49
SV4929 wecD::MudJ asmA::MudQ This study
SV5056 asmA::Cmr This study
SV5057 asmA::Kmr This study
SV5058 dcd::Kmr This study
SV5059 udk::Kmr This study
SV5061 asmA::3 FLAG This study
SV5062 asmA::3 FLAG dam230 This study
SV5084 udk::Kmr dam230 This study
SV5085 dcd::Kmr dam230 This study
SV5396 asmA::Kmr dam230 This study
SV5397 asmA::Cmr dam230 This study
SV5426 asmA::Cmr/pGE108 This study
SV5562 tolC::Cmr This study
SV5577 tolC::Cmr asmA::Kmr This study
SV5736 phoP7953::Tn10 asmA::Kmr This study
SV5809 asmA dam230 This study
SV5810 asmA dam230 marA::Kmr This study
TT1704 his-9533 J. R. Roth
TT10288 hisD9953::MudJ his-9944::MudA 24
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HindIII fragment of plasmid pIZ53 as a probe; this fragment contains the Tn5
kanamycin resistance gene, which is the same Kmr determinant carried by the
MudJ element. The DNA fragments obtained, all 2 to 3 kb long, were treated
overnight with T4 ligase at 15°C and PCR amplified with primers derived from
the MudJ DNA sequence: 5 AGC TGT GCT CGA CGT TGT CA 3 and 5
CGA ATA ATC CAA TGT CCT CC 3. If unspecific amplification had oc-
curred, its products were used as templates for a second round of PCR ampli-
fication using two additional MudJ primers: 5 GAT CTG GAC GAA GAG
CAT C 3 and 5 ATT GCA CTA CAG GTT GCA AG 3. Whenever PCR
amplification was successful, the amplification product was purified with the
GFX PCR DNA and gel band purification kit (Amersham Biosciences) and
cloned onto pGEM-T Easy (Promega Corporation, Madison, WI). Standard
DNA sequencing was performed with T3 and T7 primers.
Tagging of the AsmA protein with a 3 FLAG epitope. Addition of a 3
FLAG epitope tag at the 3 end of the asmA gene was carried out using plasmid
pSUB11 (Kmr, 3 FLAG) as template (54). An S. enterica chromosomal frag-
ment containing the appropriate region of the asmA gene was PCR amplified
using primers 5 GGA AAT TTT CGC GGT AAC CAC AAT AAC GAG GAA
GTC TAT GGT GTA GGC TGG AGC TGC TTC 3 and 5 CCA GAA TAG
ACG CCA TGT CTT CAC TCT GGG ATT TGC GAA TCA TAT GAA TAT
CCT CCT TAG 3. The resulting PCR fragment was purified and used to
electroporate an ATCC 14028 derivative carrying pKD46. Transformants were
selected on LB-kanamycin. Incorporation of the 3 FLAG tag was verified by
PCR amplification and DNA sequencing. The primers used for this amplification
were 5 AAT GAA GGA TGT CGG GCA TC 3 and 5 CGT GCC AGT AAC
GTT CTT CG 3.
Subcellular fractionation. Bacteria were fractionated as described elsewhere
(44). Briefly, bacteria were grown overnight in LB medium at 37°C with vigorous
shaking (200 rpm) and spun down by centrifugation at 15,000  g for 15 min at
4°C. These bacteria were suspended in cold phosphate-buffered saline (PBS; pH
7.4) buffer and either mixed with Laemmli buffer (total protein extract) or
disrupted by sonication. Unbroken cells were further removed by low-speed
centrifugation, 5,000  g for 5 min at 4°C. The supernatant was centrifuged at
high speed (200,000  g, 15 min, 4°C), and the new supernatant was recovered
as cytosol fraction. The pellet containing envelope material was suspended in
PBS containing 1% Triton X-100. Upon incubation of this material for 1.5 h at
4°C, the sample was centrifuged at 15,000 g for 30 min at 4°C. The supernatant
contained mostly soluble inner membrane proteins. The insoluble fraction en-
riched in OMPs was prepared upon suspension of the pellet in PBS, pH 7.4. An
appropriate volume of Laemmli buffer was added to all fractions, and upon
heating (100°C, 5 min) and clearing by centrifugation (15,000  g for 5 min at
room temperature), samples were analyzed for protein content by sodium do-
decyl sulfate-polyacrylamide gel electrophoresis in Tris-Tricine buffer by using
8% or 10% acrylamide gels.
Western blotting. The AsmA protein was detected using anti-FLAG M2
monoclonal antibody (1:10,000; Sigma Chemical Co.) and anti-mouse horserad-
ish peroxidase-conjugated secondary antibody (Bio-Rad, Hercules, CA).
Quantitative reverse transcriptase PCR (RT-PCR; real-time PCR) and cal-
culation of relative expression levels. Salmonella RNA was extracted from ex-
ponential- and stationary-phase cultures using the SV total RNA isolation system
(Promega Corporation, Madison, WI) according to the manufacturer’s instruc-
tions. The quantity and quality of the extracted RNA were determined using an
ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE). To
diminish genomic DNA contamination, the preparation was treated with DNase
I (Turbo DNA free; Applied Biosystems/Ambion, Austin, TX). An aliquot of 0.6
g of DNase I-treated RNA was used for cDNA synthesis using the high-capacity
cDNA archive kit (Applied Biosystems, Foster City, CA). Real-time PCRs were
performed in an Applied Biosystems 7500 Fast Real-Time PCR System. Each
reaction was carried out in a total volume of 15 l on a 96-well optical reaction
plate (Applied Biosystems) containing 7.5 l Power SYBR green PCR Master
Mix (Applied Biosystems), 6.9 l cDNA (1/10 dilution), and two gene-specific
primers at a final concentration of 0.2 M each. Real-time cycling conditions
were as follows: (i) 95°C for 10 min and (ii) 40 cycles at 95°C for 15 s and 60°C
for 1 min. No-template controls were included for each primer set and template.
Melting-curve analysis verified that each reaction contained a single PCR prod-
uct. Reported gene expression levels were normalized to transcripts of ompA, a
housekeeping gene that served as an internal control. Gene-specific primers,
designed with Primer Express v2.0.0 software, were as follows: for ompA, 5 TGT
AAG CGT CAG AA CCG ATA CG 3 and 5 GAG CAA CCT GGA TCC
GAA AG 3; for marA, 5 AGA GCA ACG AGC CCA TTC TC 3 and 5 GGG
TCA ATG TTT GCT GTG AC 3; and for acrA, 5 TTT GCG CGC CAT CTT
CCC 3 and 5 GAC GTG CGC GAA CGA AC 3.
Virulence assays in mice. Groups of three to four 8-week-old female BALB/c
mice (Charles River Laboratories, Santa Perpetua de Mogoda, Spain) were
inoculated with a 1:1 ratio of two strains. For oral inoculation, bacterial cultures
were grown overnight at 37°C in LB without shaking. Each strain was grown
overnight at 37°C in LB with shaking, diluted into fresh medium (1:100), and
grown to an optical density at 600 nm of 0.3 to 0.6. Oral inoculation was
performed by feeding the mice with 25 l of saline containing 0.1% lactose and
108 bacterial CFU. Intraperitoneal inoculation was performed with 0.2 ml of
saline containing 105 CFU. Salmonellae were recovered from spleen 48 h after
inoculation, and CFU were enumerated on LB and on selective medium. A
competitive index (CI) for each mutant was calculated as the ratio between the
mutant and the wild-type strain in the output (bacteria recovered from the host
after infection) divided by their ratio in the input (initial inoculum) (6). The
“cancelled out” CI (COI) is the CI corresponding to mixed infections of double
mutants with corresponding single mutant strains and is defined as the ratio
between a double mutant strain and the corresponding single mutant in the
output divided by their ratio in the input (6).
Invasion assay in HeLa epithelial cells with mixed bacterial strains. HeLa
cells (ATCC CCL2) were seeded with 5 104 to 8 104 CFU the day before the
infection, using 24-well plates (Costar; Corning, New York, NY) and grown at
37°C and 5% CO2. Bacteria were grown overnight in LB at 37°C without shaking.
A 1:1 or 10:1 mix of two bacterial strains was prepared in Dulbecco modified
Eagle medium. The CFU of the two strains in the input were enumerated by
plating a dilution series of the inoculum, using the appropriate antibiotic or the
colony color to distinguish the strains. The bacterial mixture was added to HeLa
cells to reach a multiplicity of infection of 50 bacteria per eukaryotic cell. Thirty
minutes after the infection, cells were washed twice with PBS and incubated in
fresh Dulbecco modified Eagle medium containing 100 g/ml gentamicin for 90
min. Numbers of viable intracellular bacteria were obtained after lysis of infected
cells with 1% Triton X-100 and plating on appropriate medium. Strain discrim-
ination was achieved as described for the input. Infections were carried out in
triplicate. The CI in invasion is defined as the ratio between the two strains in the
output (intracellular bacteria recovered 2 hours after infection) divided by their
ratio in the input (49).
Statistical analyses. Each CI or COI value is the mean of at least three
independent infections 	 standard error. Student’s t test was used to analyze
every CI or COI. The null hypothesis was that mean CI was not significantly
different from 1. Every COI was analyzed with two null hypotheses: (i) mean is
not significantly different from 1 and (ii) mean COI is not significantly different
from the CI of the corresponding single mutant. P values of 0.05 or less were
considered significant. Student’s t test was likewise used to analyze differences in
MICs and in mRNA levels detected by quantitative RT-PCR.
-Galactosidase assays. Levels of 
-galactosidase activity were assayed as
described by Miller (27), using the CHCl3-sodium dodecyl sulfate permeabiliza-
tion procedure.
Bioinformatic analysis. Sequence alignment was carried out at http://www.ncbi
.nlm.nih.gov/BLAST/. PPSearch (http://www2.ebi.ac.uk/ppsearch) was used to
search for motifs in the asmA sequence against patterns in the PROSITE data-
base. The SignalP 3.0 algorithm (http://www.cbs.dtu.dk/services/SignalP/) pre-
dicts the location of potential signal cleavage sites in amino acid sequences.
Secondary structure prediction (helix, sheet, and coil) was carried out at http:
//www.bork.embl-heidelberg.de/SSCP/. Transmembrane segment predictions
were made using both a sliding window hydropathy plot (http://www.cbs.dtu.dk
/services/TMHMM-2.0/) and the TMpred algorithm (http://www.ch.embnet.org
/software/TMPRED_form.html) based on the analysis of naturally occurring
transmembrane-spanning segments.
RESULTS
Trials for MudJ-induced, DOC-resistant revertants of a
dam mutant. The inability of dam strains of S. enterica to grow
on plates containing 1% DOC permitted the positive selection
of isolates carrying extragenic suppressor mutations. MudJ in-
sertions that suppressed the DOC-sensitive phenotype of a
dam mutant (SV4392) were sought using this strategy. SV4392
was mutagenized with MudJ, and DOC-resistant Kmr mutants
were selected on LB-DOC-kanamycin plates. Putative sup-
pressor-carrying isolates were lysed with P22 HT, and the ly-
sates were used to transduce SV4392, selecting Kmr. A 100%
linkage between DOC resistance and Kmr resistance con-
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firmed the existence of a suppressor mutation induced by
MudJ. To identify the loci where the MudJ element had in-
serted, the boundaries of MudJ insertions were amplified by
reverse PCR and sequenced. This procedure provided us with
three independent MudJ insertions in asmA. In both E. coli
and S. enterica, the asmA locus lies between yegH and dcd.
DNA analysis in silico indicated that asmA is transcribed in the
same orientation as that of the udk and dcd genes encoding
uridine/cytidine kinase and dihydrouridine triphosphatase, re-
spectively (Fig. 1). However, in silico analysis did not provide
evidence that asmA, udk, and dcd might be part of the same
transcriptional unit (see below).
Disruption of asmA caused a 20-fold increase in DOC re-
sistance (Table 2). Only one asmA::MudJ insertion allele is
included in Table 2 because all three showed identical sup-
pressor abilities. Strains carrying null asmA alleles constructed
by gene targeting (SV5056 and SV5057) had identical pheno-
types (Table 2).
Suppression of bile sensitivity in dammutants is specifically
caused by asmA disruption. Although no evidence exists that
the clustered dcd, udk, and asmA genes might be part of the
same transcriptional unit (30), the dcd and udk genes were
disrupted, and the ability of dcd and udk mutations to suppress
bile sensitivity in dam strains was tested. Neither mutation was
able to increase resistance to DOC in a dam background (Ta-
ble 2). In fact, disruption of dcd caused moderate sensitivity to
DOC (Table 2). Lack of dUTPase is known to induce the SOS
response as a consequence of replication impairment (37).
Because bile salts may also impair DNA replication (39), it is
not surprising that lack of dUTPase renders the cell bile sen-
sitive. For the purpose of this study, however, the relevant
observation was that neither udk nor dcd mutations were sup-
pressors of bile sensitivity. A corollary was that udk and dcd
knockouts were not polar on asmA, thus supporting the view
that asmA may be part of an independent transcriptional unit
as previously proposed for E. coli (30).
Additional support for the conclusion that the lack of AsmA
suppressed bile sensitivity in a dam background was provided
by complementation analysis using a previously described
“drop” assay (44). A plasmid carrying the asmA gene under the
control of the arabinose-inducible pBAD promoter (pIZ1581)
was constructed for this purpose. Arabinose-induced asmA
expression did not impair growth of the wild type (ATCC
14028/pIZ1581) in LB (data not shown). Plasmid pIZ1581 was
introduced in a dam asmA strain (SV4704), and growth on
LB-DOC plates containing either glucose or arabinose was
tested. As shown in Fig. 2, the dam asmA derivative carrying
pIZ1581 grew in the presence of glucose but not in the pres-
ence of arabinose, indicating that expression of the plasmid-
borne asmA gene restored bile sensitivity.
Expression of the asmA gene is not under Dam methylation
control. Because the asmA gene conferred bile sensitivity when
expressed from a heterologous promoter, we considered the
possibility that asmA expression might be under Dam methyl-
ation control. Specifically, repression of asmA by Dam might
be required for bile resistance, and uncontrolled expression
might occur in dam mutants, resulting in bile sensitivity. This
possibility was examined by comparing the expression of a
MudJ-induced transcriptional asmA::lac fusion in dam and
dam hosts (strains SV4708 and SV4704, respectively). The
fusion showed similar 
-galactosidase activities in the two
backgrounds: 120 	 18 Miller units in SV4708 and 138 	 28
FIG. 1. Diagram showing known and putative genes in the 2208 to
2215 region of the chromosome of Salmonella enterica serovar Typhi-
murium. This region corresponds to centisome 45 on the genetic map.
The diagram is based on the sequence of strain LT2, but the same gene
arrangement is found in SL1344 and ATCC 14028 (data not shown).
TABLE 2. MIC of DOC in strains carrying dam, asmA, dcd, udk,
phoP, wec, tolC, and marA mutations, alone or combined
Strain Genotype MIC (g/100 ml)of DOC
ATCC 14028 Wild type 7
SV4536 dam230 0.2
SV4708 asmA1::MudJ 9
SV4704 asmA1::MudJ dam201::Tn10dTc 6
SV5057 asmA::Kmr 9
SV5396 asmA::Kmr dam230 7
SV5056 asmA::Cmr 9
SV5397 asmA::Cmr dam230 6
SV5058 dcd::Kmr 4
SV5085 dcd::Kmr dam230 0.2
SV5059 udk::Kmr 7
SV5084 udk::Kmr dam230 0.2
SV4699 phoP7953::Tn10 0.5
SV5736 phoP7953::Tn10 asmA::Kmr 4
SV4759 wecA::Tn10dTc 2
SV4813 wecA::Tn10dTc asmA::MudJ 7
SV4429 wecD::MudJ 1
SV4929 wecD::MudJ asmA::MudQ 5
SV5562 tolC::Cmr 0.02
SV5577 tolC::Cmr asmA::Kmr 0.02
SV5809 asmA dam230 7
SV5810 asmA dam230 marA::Kmr 3
FIG. 2. Complementation analysis of DOC sensitivity in an asmA
mutant. Ten microliters of the appropriate dilutions of exponential
cultures of the wild-type and mutant strains, each containing 104 CFU,
was incubated for 24 h at 37°C in an LB plate containing 1% DOC and
0.2% glucose (top) or an LB plate containing 1% DOC and 0.2%
arabinose (bottom). Strains were ATCC 14028 (wild type), SV4536
(dam230), and SV4742 (dam230/pIZ1581).
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Miller units in SV4704. Hence, asmA transcription does not
seem to be under Dam methylation control. This conclusion is
further supported by a transcriptomic study which detected
similar levels of asmA mRNA in dam and dam hosts (2).
Lack of AsmA suppresses bile sensitivity in phoP and wec
mutants. The ability of asmA mutations to suppress bile sen-
sitivity in dam mutants raised the question of whether suppres-
sion was dam specific or broader. This issue was investigated by
constructing asmA derivatives in other S. enterica mutants
known to be bile sensitive, such as phoP (55) and wec (45)
strains. Albeit it was less efficient than in dam asmA mutants,
suppression was observed in both phoP asmA and wecA asmA
strains (Table 2). Introduction of an asmA mutation in the wild
type also caused a small but significant increase in the MIC of
DOC (Table 2).
Lack of AsmA causes transcriptional activation of the
marRAB operon but does not affect acrAB expression. The ob-
servation that asmA mutations behaved as broad suppressors
of bile sensitivity suggested the potential involvement of a cell
response able to exert its effects in a variety of genetic back-
grounds. One response of this kind in enteric bacteria is tran-
scriptional activation of the marRAB operon, which in turn
controls the so-called “Mar regulon” involved in resistance to
multiple toxic substances including bile (1). On these grounds,
we investigated whether lack of AsmA increased the level of
marA mRNA. Quantitative RT-PCR data shown in Fig. 3
unambiguously indicated that asmA mutants contained higher
levels of marA mRNA than did the wild type (Fig. 3A). In-
creased marA mRNA levels were also found in pairwise com-
parisons between dam, phoP, and wec mutants and isogenic
asmA derivatives (Fig. 3B). These observations provided evi-
dence that lack of AsmA activates marRAB expression. Be-
cause marRAB activation is known to enhance bile resistance
in S. enterica (41), we tentatively correlated marRAB activation
with the ability of asmA mutations to behave as suppressors
and enhancers of bile resistance. Furthermore, the ability of
asmA mutations to suppress bile sensitivity in dam mutants was
greatly reduced in the absence of MarA (Table 2), thus pro-
viding additional evidence that asmA mutations confer bile
resistance by activating the Mar regulon.
Quantitative RT-PCR experiments were likewise performed
to monitor expression of the acrAB operon in asmA and
asmA strains. AcrAB-TolC is an efflux pump regulated by
MarRAB-dependent and MarRAB-independent mechanisms
(41, 46) and previously shown to enhance bile resistance in S.
enterica (41). The amounts of acrA mRNA in the wild type and
in an asmA mutant were thus compared. Statistical analysis
indicated that the small differences found were not significant.
Even more clear was the absence of differences in acrA mRNA
content in pairwise comparisons between dam and dam asmA,
phoP and phoP asmA, and wecD and wecD asmA strains (data
not shown). Altogether, these results indicated that lack of
AsmA does not increase acrAB transcription and suggested
that bile resistance mediated by asmA mutations may involve
MarRAB-regulated genes other than acrAB. The observation
that suppression of bile sensitivity by asmA mutations requires
TolC (Table 2) suggests that TolC-dependent efflux pumps
other than AcrAB may be involved in MarRAB-mediated bile
resistance. An alternative possibility is that tolC mutations may
cause an envelope defect that does not permit suppression by
asmA mutations.
Lack of AsmA does not increase resistance to tetracycline.
The finding that asmA mutations activated expression of
marRAB but not acrAB was at first sight perplexing, given the
ability of the AcrAB efflux pump to enhance bile resistance
(41). Hence, we examined whether asmA mutations affected
tetracycline resistance, another well-known phenotype associ-
ated with AcrAB expression (36). The MIC of tetracycline
hydrochloride was 0.5 mg/liter for ATCC 14028 and 0.4 mg/
liter for an isogenic asmA mutant (SV5057). This observation
provided further evidence that lack of AsmA does not activate
acrAB expression.
Lack of AsmA reduces SOS induction by DOC. Previous
studies had shown that exposure of S. enterica to bile salts
induces the SOS response (39, 40). To investigate whether
suppression of bile sensitivity by asmA mutations was accom-
panied by reduced bile-induced DNA damage, induction of the
SOS system was monitored using a cea::lacZ fusion carried on
pGE108 (47). The 
-galactosidase activities of the cea::lacZ
fusion were 749 	 45 Miller units in ATCC 14028/pGE108
versus 319 	 20 Miller units in an isogenic asmA derivative,
SV5426 (means and standard deviations of three independent
experiments). Reduced SOS induction in the presence of DOC
further supports the view that lack of AsmA enhances bile
resistance.
In silico analysis of AsmA protein structure. Sequence
alignment using BLAST (NCBI database) detected no rela-
tives of the AsmA protein with known function up to an E
FIG. 3. (A) Relative amounts of marA mRNA in exponential and
stationary cultures of the wild type (ATCC 14028, gray histograms)
and of an asmA mutant (SV5057, black histograms). RNA amounts
were normalized using ompA mRNA as a control. (B) Relative
amounts of marA mRNA, normalized to ompA mRNA, in exponential
cultures of dam, phoP, and wecD mutants and in isogenic asmA deriv-
atives. The strains used were as follows: dam (SV4536), dam asmA
(SV4704), phoP (SV4699), phoP asmA (SV5736), wecD (SV4429), and
wecD asmA (SV4929) strains. In both panels, bars represent averages
and standard deviations from three independent experiments.
VOL. 191, 2009 VIRULENCE-RELATED ROLES OF S. ENTERICA AsmA 3619
 o
n
 February 26, 2016 by INSTITUTO
 DE PARASITO
LO
G
FA Y
http://jb.asm.org/
D
ow
nloaded from
 
value of e8 (data not shown). To characterize structural fea-
tures of the S. enterica AsmA gene product (accession number
gi29141254, NCBI), secondary structure content (percentages
of alpha-helix, beta-sheet, and coil) was predicted based on
both amino acid sequence and composition. The results indi-
cated that the secondary structure of AsmA is characterized by
high alpha-helix and coil content (47.0 and 41.8%, respec-
tively) and low beta-sheet content (11.8%). In turn, in silico
analysis of AsmA supersecondary structure (transmembrane
segments, signal peptides, and motifs) suggested that AsmA
has one transmembrane segment, from amino acid 5 to amino
acid 26; an N-terminal signal peptide; and one cleavable site
between amino acids 25 and 26 (VLL-VN). These results imply
that AsmA may be a secreted protein. A signal typical of
secreted proteins has been also described for the AsmA amino
acid sequence of E. coli (30).
The Salmonella enterica AsmA protein localizes in the outer
membrane. Construction of an AsmA protein derivative
tagged with a 3 FLAG epitope permitted the detection of
AsmA by Western immunoblot analysis. The tagged AsmA
variant proved to be functional, since the MIC of DOC for
strain SV5062 (asmA::3FLAG dam) was identical to that for
the dam strain SV4536 (data not shown). An electrophoretic
separation of cell fractions (cytosol, cytoplasmic membrane,
and outer membrane) is shown in Fig. 4 (left panel). Western
analysis of the separated protein preparations was carried out
with a commercial anti-FLAG antibody. The results unambig-
uously showed that AsmA is located in the S. enterica outer
membrane (Fig. 4, right panel). This result involves a discrep-
ancy with a previous study indicating that AsmA is a cytoplas-
mic membrane protein in E. coli (30).
Lack of AsmA causes attenuation of virulence in mice by the
oral route. A previous study showed that mutHLS mutations,
which suppress bile sensitivity in dam mutants of Salmonella,
caused partial relief of virulence attenuation: dam mutHLS
mutants were found to be 100 times more virulent than the
parental dam strain (39). To investigate whether suppression
of bile sensitivity by asmA mutations likewise resulted in at-
tenuation relief, we compared the virulence of a dam mutant
with that of a dam asmA mutant. Mixed infections were carried
out in BALB/c mice upon inoculation by the oral route, and a
COI was calculated. As a control, the CI of the dam mutant
versus the wild type was also calculated. To facilitate colony
identification after recovery of bacterial cells from the animal
spleen, strain SV4873 (trg::MudJ) (49) was used as the wild
type instead of ATCC 14028. Null trg mutations have been
previously shown to be neutral for Salmonella virulence (49).
Competitive infection experiments, summarized in Fig. 5, in-
dicated that lack of AsmA does not relieve attenuation in a
dam strain despite the fact that an asmA mutation renders dam
mutants bile resistant (Table 2). This paradox suggested that
lack of AsmA might impair Salmonella virulence on its own.
This possibility was confirmed in mixed infections using
SV4873 (trg) and SV4708 (asmA): the CI of the asmA mutant
was found to be 30- to 40-fold lower than that of the virulent
strain SV4873 (Fig. 5). As a control, strains carrying two dif-
ferent asmA alleles (SV4708 and SV5057) were also subjected
to competitive infection of mice. No difference was found be-
tween the asmA::MudJ allele and the asmA::Cmr allele (Fig.
5), providing further evidence that lack of AsmA causes oral
attenuation. Mixed infections by the intraperitoneal route pro-
vided small, nonsignificant differences between SV4873 (trg)
and SV4708 (asmA) (data not shown), suggesting that asmA
mutations may hamper S. enterica serovar Typhimurium viru-
lence in the mouse intestine but not in further stages of infec-
tion.
Lack of AsmA causes an invasion defect. Because lack of
AsmA does not affect growth in standard media, we reasoned
that attenuation of asmA mutants by the oral route might
reflect impaired interaction of bacteria with animal tissues. To
test this hypothesis, we compared the ability of an asmA mu-
tant to invade epithelial (HeLa) cells with that of a fully inva-
sive strain, SV4873. CI analysis upon mixed infection with
SV4708 (asmA) and SV4873 (trg) indicated that the CI for the
asmA mutant was around 0.2. Hence, lack of AsmA causes a
partial impairment for invasion of nonphagocytic cells, indicat-
ing that the presence of AsmA in the S. enterica outer mem-
FIG. 4. Distribution of the AsmA protein tagged with a 3 FLAG
epitope in subcellular fractions of S. enterica serovar Typhimurium
(strain SV5061). Coomassie blue-stained proteins (left) and anti-
FLAG Western hybridization (right) are shown for the following frac-
tions: total protein (TP), cytosol (Cyt), inner membrane (IM), and
outer membrane (OM). The volume loaded for all fractions was nor-
malized to the same number of bacteria (5  107 CFU). The positions
of the AsmA-FLAG protein and the prestained molecular mass stan-
dards in kDa are indicated.
FIG. 5. CI and COI analysis of dam, asmA, and dam asmA strains
after oral infection of BALB/c mice. Mixed infections were as follows:
wild-type strain (SV4873)/dam strain (SV4536), dam strain (SV4536)/
dam asmA strain (SV4704), wild-type strain (SV4873)/asmA strain
(SV4708), and asmA strain (SV4708)/asmA strain (SV5057). The CIs
represented are the means from four infections. Error bars represent
the standard deviations.
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brane may be required to trigger efficient bacterial uptake by
nonphagocytic cells.
DISCUSSION
The ability of asmA mutations to enhance bile resistance in
various genetic backgrounds suggested the involvement of a
general mechanism such as mutational activation of a defense
response. Note that the causes of bile sensitivity in dam, phoP,
and wec mutants of S. enterica are diverse, perhaps unrelated
(31, 39, 44, 45), and that enhanced bile resistance is also ob-
served upon introduction of asmA null alleles in the wild type
(Table 2). We provide evidence that the general mechanism by
which asmA mutations enhance bile resistance in diverse ge-
netic backgrounds involves transcriptional activation of the
marRAB operon (Fig. 3). Initially identified in E. coli (17) and
later in S. enterica (51), the marRAB operon plays a major role
in the response of enteric bacteria to toxic substances (1). One
of its products, MarA, is a transcriptional regulator that con-
trols multiple genes which constitute the so-called “Mar regu-
lon” (3). In S. enterica, transcription of marAB is activated by
bile in a dose-dependent manner (41). This activation confers
bile resistance, presumably via MarA-mediated activation of
acrAB and other unidentified genes of the Mar regulon (41).
Our observation that asmA mutants undergo increased
marRAB expression can likewise explain their ability to increase
bile resistance.
The mechanism of marRAB activation in asmA mutants re-
mains to be studied. Bioinformatic analysis indicates that
AsmA is unrelated to any known transport protein. A dual role
of AsmA as a membrane component and a transcriptional
regulator cannot be ruled out (32) but seems a priori unlikely
because a putative DNA-binding domain is not found in
AsmA. Hence, a tentative hypothesis is that lack of AsmA may
cause an outer membrane reorganization that directly or indi-
rectly results in marRAB activation. The possibility that AsmA
absence causes changes in the outer membrane has been pre-
viously proposed to explain the phenotypes of E. coli asmA
mutants (11, 56). On the other hand, the Mar regulon is known
to respond to many kinds of stimuli, including intake of anti-
biotics, oxidative stress, and metabolic signals (3, 12, 28).
Hence, it is conceivable that the absence of AsmA in the outer
membrane may generate a signal that results in Mar regulon
activation. An analogy may be found in the RcsBCD signaling
system (25), which is activated by external stimuli but also
responds to envelope perturbations caused by mdo mutations
(13).
The mechanism by which marRAB activation in asmA mu-
tants enhances bile resistance remains also to be identified.
MarA regulates, either up or down, at least 60 genes (3).
Hence, bile resistance in asmA mutants might result from
activation or repression of genes of the Mar regulon. Although
OmpF is known to be under MarRAB control (1), the possi-
bility that bile resistance in asmA mutants might result from
reduced OmpF synthesis was ruled out since a previous study
had shown that lack of AsmA does not affect assembly of
wild-type OMPs in E. coli (30). The list of genes under MarA
control includes also the components of an efflux pump be-
longing to the RND family (AcrAB-TolC), which is known to
transport bile salts (46). However, asmA mutations do not
increase transcription of acrA, suggesting that increased bile
resistance in asmA mutants is caused by altered expression of
Mar-regulated genes other than acrAB. The fact that asmA
mutations activate transcription of marRAB but not of acrAB is
curious but not unusual: regulation of acrAB expression is
known to be complex and multilayered (33, 46). A tentative
hypothesis is that asmA mutations might activate a MarA-
regulated efflux pump hitherto unknown to transport bile salts.
A more speculative possibility is that lack of AsmA might
activate one or more genes shared by the SoxRS and MarRAB
regulons (28). In support of this view, the SoxRS regulon has
been previously shown to be activated by bile salts (40), and
asmA mutations reduce SOS induction by DOC.
A priori, any mutation that restores bile resistance in bile-
sensitive mutants can be expected to favor survival of infecting
Salmonella populations during intestinal passage, thus increas-
ing their virulence by the oral route. However, asmA mutations
failed to suppress oral attenuation in dam mutants (Fig. 5).
This paradox was, however, solved when we observed that
asmA mutations caused attenuation on their own: the CI of an
asmA mutant by the oral route was found to be 30- to 40-fold
lower than that of the wild type (Fig. 5). Hence, we tentatively
infer that the benefits derived from increased bile resistance
had been compensated (in fact, overrun) by other conse-
quences associated with asmA mutations. In tests for invasion
of epithelial cells, asmA mutants displayed a fivefold reduction
in invasion capacity, suggesting that AsmA is required for
optimal invasion of the intestinal epithelium.
If lack of AsmA causes indeed a major outer membrane
rearrangement as proposed above and in a previous E. coli
study (11), reduced invasion of epithelial cells might be a direct
consequence of envelope alteration. Involvement of outer
membrane components in Salmonella invasion has been pre-
viously described (8, 50). An alternative possibility is that un-
controlled activation of the Mar regulon might impair the
interaction between Salmonella and epithelial cells. However,
a previous study has shown that the marRAB operon is dis-
pensable for virulence in the mouse model (51).
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